ACTU 10-Q: SEC filing

Actuate Therapeutics

Filed with the SEC on Nov 13, 2026 · accession 0001683168-26-008697

ACTU filed a 10-Q (quarterly report) with the SEC on Nov 13, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -3.6% by the first close after the filing.

Summary of the filing

Actuate Therapeutics filed its quarterly 10-Q report for Q3 2026, disclosing financial results and ongoing clinical development activities for the period ended September 30, 2026.

For details, click here →How to read a 10-Q →

Key details

FilerActuate Therapeutics, Inc.

Underwriter/placement agentNewbridge Securities Corporation

How ACTU stock reacted

Close before

$0.30

Nov 12, 2026

First close after

-3.61%

$0.29

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ACTU, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ACTU?

Click here

Frequently asked questions

What did ACTU file with the SEC on Nov 13, 2026?

ACTU filed a 10-Q (SEC filing). Actuate Therapeutics filed its quarterly 10-Q report for Q3 2026, disclosing financial results and ongoing clinical development activities for the period ended September 30, 2026.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did ACTU stock react to this filing?

ACTU closed at $0.30 before the filing and $0.29 on Nov 13, 2026 (-3.61%).

Other ACTU SEC filings

Get alerts when ACTU files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

ACTU overview ACTU analysis ACTU news Latest SEC filings